Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating guadecitabine plus pembrolizumab in recurrent ovarian, primary peritoneal, or fallopian tube cancer has completed w…
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer [Phase 2]
Phase 2 trial update for SC10914 in patients with gBRCA1/2-mutated advanced ovarian cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. [Phase 4]
Phase 4 trial comparing oral iron to placebo in newly diagnosed gynecologic oncology patients who are surgical candidates; completed.
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer [Phase 2]
Phase II study of Intraperitoneal NanoPac in ovarian cancer was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Ovarian Dendritic Cell Vaccine Trial [Phase 2]
A Phase 2 clinical trial update for an ovarian cancer dendritic cell vaccine; current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial update of DCVAC/OvCa as follow-up after standard chemotherapy in women with relapse of platinum-sensitive epithelial ovarian c…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging [NA]
Clinical trial evaluating multimodal functional imaging to assess response to neoadjuvant chemotherapy in advanced ovarian cancer has comple…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Olaparib Maintenance With Pembrolizumab & Bevacizumab in BRCA Non-mutated Patients With Platinum-sensitive Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating olaparib maintenance with pembrolizumab and bevacizumab in BRCA wild-type, platinum-sensitive recurrent ovarian can…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating sensitivity to different chemotherapy regimens in platinum-partial sensitive recurrent ovarian cancer is in progr…
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Study of DP303c Injection in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial update for DP303c Injection in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Study of Azacitidine and Durvalumab in Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating azacitidine with durvalumab in advanced solid tumors has completed enrollment with conditions including microsatell…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel, polyglutamate paclitaxel, or observation in advanced ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2021-03-25Clinical Trial Update: PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating a PD-1 antibody in combination with neoadjuvant chemotherapy for ovarian cancer; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating tumor-infiltrating lymphocyte (TIL) therapy in combination with checkpoint inhibitors for metastatic ovarian ca…
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating chiauranib in combination with chemotherapy for ovarian cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Short-course HIPEC in Advanced Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial update on short-course HIPEC for advanced epithelial ovarian cancer completed.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer [Phase 2]
Phase 2 trial update for camrelizumab in combination with apatinib in recurrent platinum-resistant ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update comparing olaparib alone or the combination of cediranib plus olaparib against standard chemotherapy in platinum-sensit…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
A phase 3 trial compares olaparib alone or the combination of cediranib and olaparib versus standard chemotherapy for women with platinum-se…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer [Phase 2]
Phase 2 randomized study evaluating safety and efficacy of Pazopanib plus Gemcitabine in persistent or relapsed ovarian cancer (and related …
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer [Phase 2]
Phase 2 trial update for NUC-1031 in platinum-resistant ovarian cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors [Phase 1]
Phase 1 first-in-human study evaluating mirvetuximab soravtansine in adults with ovarian cancer and other FOLR1-positive solid tumors; study…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations [Phase 1, Phase 2]
Pilot trial of BMN 673 (olaparib) in advanced solid tumors with deleterious BRCA mutations completed phases 1 and 2; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers [Phase 2]
Phase 2 pilot study evaluating durvalumab with Vigil in advanced women's cancers has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) [Phase 1]
Phase 1 trial evaluating safety and tolerability of an MVA-based vaccine expressing brachyury and T-cell costimulatory molecules (MVA-Brachy…